BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)
Clinical trial NCT01856933 · COMPLETED
Trial details
- NCT number
- NCT01856933
- Sponsor
- Heinrich Elinzano, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-11-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.